State of the Art Management of IBD: How Should We Sequence Therapies and Monitor the Disease?

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

The Future of IBD Therapy: Expert Perspectives on Biosimilars
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Medical Therapy
The Future of IBD Therapy: Expert Perspectives on Biosimilars
- Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
- Ross M. Maltz, MD
- Melissa Kirkpatrick, PharmD, BCACP
Complicated Crohn’s Disease Cases: Perianal Disease, Intra-abdominal Abscess, & Strictures
Complicated Crohn’s Disease Cases: Perianal Disease, Intra-abdominal Abscess, & Strictures
CME/CE
Complicated Crohn’s Disease Cases: Perianal Disease, Intra-abdominal Abscess, & Strictures
- David A. Schwartz, MD
- Ira Leeds, MD, FACS, FASCRS
Pathogenesis of IBD
Pathogenesis of IBD
Medical Therapy
Pathogenesis of IBD
- Michele Rubin, APN, CNS, CGRN
Scripps Conference: New Advances in Inflammatory Bowel Disease
Practical Use of Biomarkers in IBD – Clinical Guidelines
Scripps Conference: New Advances in Inflammatory Bowel Disease
Practical Use of Biomarkers in IBD – Clinical Guidelines
Medical Therapy
Scripps Conference: New Advances in Inflammatory Bowel Disease
Practical Use of Biomarkers in IBD – Clinical Guidelines
- Benjamin L. Cohen, MD